Lactobacillus plantarum LP-Onlly alters the gut flora and attenuates colitis by inducing microbiome alteration in interleukin-10 knockout mice

Molecular Medicine Reports

Volumn 16, Issue 5, 2017, Pages 5979-5985

  Chen, Hongqi ^a   Xia, Yang ^a   Zhu, Sibo ^b   Yang, Jun ^a   Yao, Jing ^a   Di, Jianzhong ^a   Liang, Yong ^a   Gao, Renyuan ^a   Wu, Wen ^a   Yang, Yongzhi ^a   Shi, Chenzhang ^a   Hu, Desheng ^a   Qin, Huanlong ^a   Wang, Zhigang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Cinoasia Institute   (China)

Author keywords

Colitis; Interleukin 10 knockout mice; Lactobacillus plantarum; Metagenomics

Indexed keywords

BACTERIAL DNA; GENOMIC DNA; INTERLEUKIN 10; PROBIOTIC AGENT; IL10 PROTEIN, MOUSE;

AKKERMANSIA MUCINIPHILA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDES; BACTEROIDES SALANITRONIS; BACTEROIDES UNIFORMIS; BACTEROIDETES; CELL CYCLE REGULATION; CELL MIGRATION; CELL TRANSPORT; CELLULAR SECRETION; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL COLITIS; FEMALE; FIRMICUTES; GENOME SIZE; HELICOBACTER HEPATICUS; HUMAN; INTESTINE FLORA; KNOCKOUT MOUSE; LACTOBACILLUS PLANTARUM; METAGENOME; MOUSE; NONHUMAN; PARABACTEROIDES DISTASONIS; RECOMBINATION REPAIR; SPECIES COMPOSITION; TAXONOMY; ACTINOBACTERIA; ANIMAL; CLASSIFICATION; COLITIS; DEFICIENCY; DISEASE MODEL; GENE DELETION; GENETICS; HIGH THROUGHPUT SEQUENCING; HOMOZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PROTEOBACTERIA;

ACTINOBACTERIA; ANIMALS; BACTEROIDETES; COLITIS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FEMALE; FIRMICUTES; GASTROINTESTINAL MICROBIOME; GENE DELETION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOMOZYGOTE; INTERLEUKIN-10; LACTOBACILLUS PLANTARUM; MICE; MICE, KNOCKOUT; PROBIOTICS; PROTEOBACTERIA;

EID: 85030089580     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.7351     Document Type: Article

References (34)

1. Guarner F and Malagelada JR: Gut flora in health and disease. Lancet 361:512-519, 2003.
2. Ussar S, Griffin N W, Bezy O, Fujisaka S, Vienberg S, Softic S, Deng L, Bry L, Gordon JI and Kahn CR: Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab 22:516-530, 2015.
3. Abraham C and Cho JH: Inflammatory bowel disease. N Engl J Med 361:2066-2078, 2009.
4. Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, et al: Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility. Biomed Res Int 2013:435268, 2013.
5. Hansen JJ: Immune responses to intestinal microbes in inflammatory bowel diseases. Curr Allergy Asthma Rep 15:61, 2015.
6. Rup L: The human microbiome project. Indian J Microbiol 52:315, 2012.
7. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, Methé BA and Huttenhower C: The human microbiome project: A community resource for the healthy human microbiome. PLoS Biol 10:e1001377, 2012.
8. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN and Schreiber S: Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685-693, 2004.
9. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, Le Leiko N, Snapper SB, et al: Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13:R79, 2012.
10. Sokol H, Lay C, Seksik P and Tannock GW: Analysis of bacterial bowel communities of IBD patients: What has it revealed? Inflamm Bowel Dis 14:858-867, 2008.
11. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M and Lochs H: Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54, 2002.
12. Petschow B, Doré J, Hibberd P, Dinan T, Reid G, Blaser M, Cani PD, Degnan FH, Foster J, Gibson G, et al: Probiotics, prebiotics, and the host microbiome: The science of translation. Ann N Y Acad Sci 1306:1-17, 2013.
13. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM and Axon AT: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 354:635-639, 1999.
14. Prantera C and Scribano ML: Probiotics and Crohn's disease. Dig Liver Dis 34(Suppl 2):S66-S67, 2002.
15. Hedin C, Whelan K and Lindsay JO: Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. Proc Nutr Soc 66:307-315, 2007.
16. Gibson GR: Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129(7 Suppl):1438S-1441S, 1999.
17. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620-1633, 2004.
18. Everard A, Lazarevic V, Gaïa N, Johansson M, Ståhlman M, Backhed F, Delzenne NM, Schrenzel J, François P and Cani PD: Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 8:2116-2130, 2014.
19. Xia Y, Chen HQ, Zhang M, Jiang YQ, Hang XM and Qin HL: Effect of Lactobacillus plantarum LP-Onlly on gut flora and colitis in interleukin-10 knockout mice. J Gastroenterol Hepatol 26:405-411, 2011.
20. Human Microbiome Project Consortium: A framework for human microbiome research. Nature 486:215-221, 2012.
21. Huma n Microbiome Project Consor tium: Structure, function and diversity of the healthy human microbiome. Nature 486:207-214, 2012.
22. Zerbino DR and Birney E: Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18:821-829, 2008.
23. Zhu W, Lomsadze A and Borodovsky M: Ab initio gene identification in metagenomic sequences. Nucleic Acids Res 38:e132, 2010.
24. Huerta-Cepas J, Szklarczyk D, Forslund K, Cook H, Heller D, Walter MC, Rattei T, Mende DR, Sunagawa S, Kuhn M, et al: eggNOG 4.5: A hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences. Nucleic Acids Res 44:D286-D293, 2016.
25. Edgar RC: MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792-1797, 2004.
26. Sinha S and Lynn AM: HMM-ModE: Implementation, benchmarking and validation with HMMER3. BMC Res Notes 7:483, 2014.
27. Dray S and Dufour AB: The ade4 package: Implementing the duality diagram for ecologists. J Stat Softw 22:20, 2007.
28. Wixon J and Kell D: The Kyoto encyclopedia of genes and genomes-KEGG. Yeast 17:48-55, 2000.
29. Markowitz VM: Microbial genome data resources. Curr Opin Biotechnol 18:267-272, 2007.
30. Ganesh BP, Klopfleisch R, Loh G and Blaut M: Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One 8:e74963, 2013.
31. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J, Verdu EF and Tlaskalova-Hogenova H: Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163:250-259, 2011.
32. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65, 2010.
33. Fenner L, Roux V, Mallet MN and Raoult D: Bacteroides massiliensis sp. nov., isolated from blood culture of a newborn. Int J Syst Evol Microbiol 55:1335-1337, 2005.
34. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA and Florin TH: Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105:2420-2428, 2010.